Expression of GFRα1 or GFRα3, particularly bound with ARTN, has been consistently associated with poor survival outcomes, so these proteins can serve as prognostic markers in specific subtypes of mammary carcinoma 32. The gene discussed is GFRA1; the disease is breast carcinoma.